|
|
|
|
Non-Hodgkin's
What's up doc? Help fight cancer in children 14 Mar 2006
MetroWest Daily News, ...in 1990, AML (another type of leukemia) went from 20 percent to 40 percent, Hodgkin's lymphoma from 50 percent to 90 percent, non-Hodgkin's lymphomas from less ...
Fund-raiser says thank you to cancer unit 14 Mar 2006
Bury Free Press, Moira Reeve was so impressed with the speed and quality of her treatment for non-hodgkin's lymphoma at West Suffolk Hospital she decided to hold a New Year's ...
Primary Non-Hodgkin's Lymphoma of Bone in Children Mar 9, 2006
Journal of Bone and Joint Surgery Background: Primary non-Hodgkin's lymphoma of bone, often more simply referred to as primary lymphoma of bone, is a rare subset of non-Hodgkin's lymphoma in ...
Shorter therapy helps non-Hodgkin's lymphoma patients Feb 15, 2006
ABC Regional Online, A new study has found that survival rates among elderly patients affected by non-Hodgkin's lymphoma has increased by using a different treatment method. ...
Rituxan earns FDA approval for aggressive non-Hodgkin's Feb 11, 2006
Cancerfacts.com, ...developed and marketed by Genentech and Biogen-Idec for use in the first-line treatment of patients with an aggressive form of non-Hodgkin's lymphoma, called ...
Drug Shows Promise For Non-Hodgkin's Lymphoma Patients Feb 16, 2006
INDYchannel.com, Doctors have a new weapon in the fight against non-Hodgkin's lymphoma, 6News' Stacia Matthews reported Thursday. The Food and Drug ...
Ernie Johnson Jr. has non-Hodgkin's lymphoma Feb 22, 2006
Atlanta Journal Constitution (subscription), Turner Sports announcer Ernie Johnson Jr. said today he will undergo treatment for non-Hodgkin's Lymphoma this summer. Johnson, host ...
Allos Therapeutics Reports 2005 Financial Results Mar 6, 2006
PR Newswire (press release), ...announced the presentation of interim results from a Phase 1/2 single-agent study of PDX in patients with relapsed or refractory non-Hodgkin's lymphoma and ...
Mom goes bald to aid cancer research Mar 12, 2006
DetNews.com, Faolan MacBeth's death from non-Hodgkin's lymphoma four years ago inspired her parents' involvement with St. Baldrick's. See full image. F aolan died. ...
A strike against cancer Mar 13, 2006
Centre Daily Times, The charity event is named in honor of Matt Knepp, an avid bowler who lost his battle with non-Hodgkin's lymphoma six years ago today. ...
Cell Therapeutics, Inc. (CTI) Reports 2005 Fourth Quarter and Year ... Mar 9, 2006
MSN Money ...applications in the United States and Europe and on reporting the interim analysis for the pixantrone phase III trial in non-Hodgkin's lymphoma," stated James A ...
Genentech and Biogen Legal Troubles - When It Rains It Pours Mar 8, 2006
OpEdNews ...by Evelyn Pringle. Rituxan gained FDA approval in 1997, as a treatment for a certain type of non-Hodgkin's lymphoma. Roughly 12,760 ...
VGX and Dowpharma sign cancer compound agreement Mar 10, 2006
In-PharmaTechnologist.com, ...development of a novel cancer compound currently in pre-clinical development that initial clinical studies will target individuals with Non-Hodgkin's Lymphoma. ...
Off-label usage of drugs gets scrutinized Mar 3, 2006
San Diego Union Tribune, Use: To treat some forms of non-Hodgkin's lymphoma. Approved Tuesday for rheumatoid arthritis. Cost: For cancer, about $20,000 for a six-treatment course. ...
Lady Elspeth Campbell: The Empress Ming Mar 11, 2006
Independent, Elspeth displayed her stoicism when Sir Menzies was diagnosed four years ago with Non-Hodgkin's lymphoma, a cancer which attacked his hip and led to months of ...
High lung cancer rate seen in North Toledo Mar 11, 2006
Toledo Blade, ...significant. One - non-Hodgkin's lymphoma - was even found to occur far less frequently than expected in the Lagrange area. The ...
Dying son's plea for justice Mar 10, 2006
NEWS.com.au, ...by creditors. Joel, 23, who has non-Hodgkin's lymphoma, said he was outraged at the treatment of his mother and Ms Ottaway. "They ...
Shelton high schoolers compete for Mr. Student Body Mar 12, 2006
Connecticut Post, Valovcin finally gave his blessing after a worthy cause for the event was found — - raising money for a recent graduate diagnosed with non-Hodgkin's lymphoma ...
Allos Therapeutics Appoints Paul L. Berns as President and CEO Mar 10, 2006
PR Newswire (press release), ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ...
Favrille Announces $45 Million Financing to Support Clinical ... Mar 7, 2006
PR Newswire (press release), ..."This will enable us to continue our clinical development of FavId for B-cell non-Hodgkin's lymphoma (NHL) while aggressively preparing for its commercial ...
Genentech, Biogen get added Rituxan OK Mar 1, 2006
BusinessWeek In February, the companies gained FDA approval to market Rituxan to treat diffuse large B-cell lymphoma, an aggressive type of non-Hodgkin's lymphoma. ...
North Port news briefs Mar 4, 2006
Charlotte Sun-Herald, For patients with blood cancers, such as non-Hodgkin's lymphoma and multiple myeloma, chemotherapy can be a double-edged sword. ...
FDA Approves Rituxan (Rituximab), the First Targeted B-Cell ... Mar 1, 2006
DG News In general, the adverse events observed in patients with RA were similar in type to those seen in patients with non-Hodgkin's lymphoma (NHL). ...
FDA Approves Rituxan® Plus Chop For First-Line Treatment Of ... Feb 12, 2006
Medical News Today (press release), FDA) has approved Rituxan® (Rituximab) for use in the first?line treatment of patients with diffuse large B-cell, CD20-positive, non-Hodgkin's lymphoma, in ...
COMUNICADO: Lilly Launches Phase III Trial of Targeted Cancer ... Mar 9, 2006
Europa Press, In addition to glioblastoma, enzastaurin is also being studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small ...
European Regulatory Committee Recommends Orphan Drug Status for ... Feb 14, 2006
Market Wire (press release) ...clinical program that is evaluating the antibody in patients with relapsed or refractory B-cell lymphomas, including Hodgkin's and non-Hodgkin's lymphomas, who ...
Lilly starts phase 3 trial of enzastaurin Mar 9, 2006
United Press International Lilly is studying whether enzastaurin could be useful in treating other cancers, including non-Hodgkin's lymphoma, colorectal cancer and non-small cell lung ...
Author's treaty book was evidence in US Supreme Court case Mar 8, 2006
Duluth News Tribune, Satz, 62, died Tuesday at Fairview University Medical Center in Minneapolis after battling non-Hodgkin's lymphoma, funeral director Jerry Speckien confirmed in ...
Eli Lilly Launches Phase III Study Of Enzastaurin For Brain Tumor ... Mar 9, 2006
Trading Markets, In addition to glioblastoma, enzastaurin has been studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small cell ...
Biogen Idec Reports Full Year and Fourth Quarter 2005 Results Feb 15, 2006
Genetic Engineering News, ...related to RITUXAN, a treatment for certain B-cell non-Hodgkin's lymphomas that Biogen Idec co-promotes in the US with Genentech. ...
Pending Rituxan Arthritis Approval Means Little To Earnings Feb 27, 2006
Forbes ...of the [supplemental biologics license application], but caution that the FDA may regard the available safety database of non-Hodgkin's lymphoma patients ...
Cell Therapeutics, Inc. CEO Talks About Lung Cancer Treatments for ... Mar 9, 2006
PharmaLive.com (press release), ...cell lung and ovarian cancers, the potential failure of pixantrone to prove safe and effective for relapsed aggressive non-Hodgkin's lymphoma, determinations ...
UPDATE 1-Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
Reuters ...(BIIB.O: Quote, Profile, Research) on Tuesday said US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis ...
Rituxan's Expanded Use OKd Mar 1, 2006
Los Angeles Times, ...and Biogen Idec Inc. on Tuesday said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...
Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
ABC News Inc. said on Tuesday US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...
US gives a second life to a major cancer drug Mar 1, 2006
International Herald Tribune, B cells. These are the ones that run amok in non- Hodgkin's lymphoma, the type of cancer for which Rituxan is approved. But the ...
Sunlight, vitamin D trade-off explored Mar 8, 2006
London Free Press, ...unprotected -- that is, not using sunscreen -- may reduce your risk of some big cancers, like breast, prostate, colorectal and non-Hodgkin's lymphoma," said ...
Vitamin D supplements may give benefits of sun without skin cancer ... Mar 8, 2006
Canada.com, ...sun unprotected - that is, not using sunscreen - may reduce your risk of some big cancers, like breast, prostate, colorectal and non-Hodgkin's lymphoma," said ...
Experts debate clear guideline on sun exposure Mar 9, 2006
CTV.ca, ...out in the sun for unprotected periods of time will reduce your risk of some cancers including breast, prostate, colorectal, ovarian and non-Hodgkin's lymphoma ...
Celgene's Revlimid Has Upside Long-Term Potential Mar 8, 2006
Forbes In addition, the Morgan Stanley analyst highlighted Revlimid’s potential in other indications such as leukemia and non-Hodgkin's lymphoma. ...
Favrille to raise $45 mln from private placement Mar 7, 2006
Reuters ...said the proceeds will be used to fund the clinical development and commercial launch of its lead product FavId, used to treat a type of non-Hodgkin's lymphoma ...
Productivity dips at end of 2005 Mar 8, 2006
San Diego Union Tribune, Favrille said it will use the money to fund the clinical development of its non-Hodgkin's lymphoma treatment, FavId. Delta Air Lines Inc. ...
MultiVu Video Feed: Rituxan: First FDA-Approved Treatment to ... Feb 10, 2006
PR Newswire (press release), 10 /PRNewswire/ -- Patients with non-Hodgkin's lymphoma, any cancer of the lymphoid tissue in which lymphocytes proliferate and grow uncontrollably, now have a ...
Louisville has high hopes for Genentech Mar 7, 2006
Louisville Courier-Journal, It has built its recent success on blockbuster cancer drugs, including Rituxan for non-Hodgkin's lymphoma and Avastin for colon cancer. ...
BioCryst Initiates Intravenous Peramivir Phase I Clinical Trial Mar 9, 2006
International News Service, Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...
Sask. to expand list of occupational illnesses linked to ... Feb 28, 2006
StarPhoenix, REGINA -- Being diagnosed with non-Hodgkin's lymphoma in 2002 was stressful enough for Regina firefighter Ivan Wagner. Discovering ...
METRO DETROIT CANCER FUND-RAISER: A long walk for a long fight Mar 1, 2006
Detroit Free Press, About 750,000 Americans and 23,000 Michiganders currently live with leukemia, Hodgkin's or non-Hodgkin's lymphoma or myeloma, all forms of blood cancer. ...
STARR REPORT Mar 10, 2006
New York Post, Gotham Comedy Club tonight through Sunday. He's recently recovered from non- Hodgkin's lymphoma. More ratings: The season premiere ...
Painting Blog Archives Mar 6, 2006
About - News & Issues, I know this from extensive research after being diagnosed with non-Hodgkin's lymphoma. It is the second fastest growing cancer type in the US". ...
Making the case for a title Mar 9, 2006
Sioux Falls Argus Leader, ...play. But during her freshman year, Dan Case was diagnosed with non-Hodgkin's lymphoma and spent much of his time in the hospital. ...
Meet a card-carrying angel Mar 9, 2006
Orlando Sentinel, ...disease's darkness. His formal training in battling cancer began in 1997 when doctors diagnosed his non-Hodgkin's lymphoma. In the ...
Shearing is sharing in cancer fight Mar 10, 2006
Detroit Free Press, For Walled Lake resident Emily MacBeth, 33, shaving her head is an act of love for her daughter Faolan, who died four years ago from non-Hodgkin's lymphoma. ...
-- Online Broadcast of Discovery Health Channel Segment on ... Feb 22, 2006
Genetic Engineering News, ...with physical examination and CT scan evidence of gross tumor remission, to gain conditional approval of BiovaxID for treating follicular non-Hodgkin's lymphoma ...
GPC Biotech's anticancer drug 1D09C3 recommended for 'orphan drug' ... Feb 14, 2006
Forbes ...orphan medicinal product designation by the European Commission for Hodgkin's lymphoma and chronic lymphocytic leukemia, a type of non-Hodgkin's lymphoma. ...
Saloky's dad inspiration for fundraiser Feb 28, 2006
phillyBurbs.com, Former swimmer Brian Crooks had a sister suffer from leukemia and both Eric Mayer and Caroline Bedesem had nuclear family members battle non-Hodgkin's lymphoma ...
Leukemia Cup races to be held Mar 2, 2006
Mobile Register, Participants raise funds to find cures for blood cancers such as leukemia, Hodgkin's and non-Hodgkin's lymphoma and myeloma and to improve the lives of ...
Genitope Corporation Initiates Clinical Trial to Evaluate MyVax(R) ... Feb 27, 2006
PR Newswire (press release), ..."Active immunotherapy, sometimes called a cancer vaccine, has shown considerable promise in treating non-Hodgkin's lymphoma," said Dan W. Denney, Jr., Ph.D ...
'Killer Cramps' Not Necessarily Serious Mar 7, 2006
Gilroy Dispatch (subscription), Several reports also suggest a link between endometriosis and a higher risk for breast cancer, non-Hodgkin's lymphoma and melanoma. ...
PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on ... Mar 9, 2006
Business Wire (press release), PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for cancer indications, including non-Hodgkin's lymphoma and solid tumors, as well as ...
Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ... Feb 14, 2006
PR Newswire (press release), ...with these challenging diseases." These data established the superior therapeutic activity of pralatrexate in models of human non-Hodgkin's lymphoma and ...
Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ... Feb 14, 2006
PharmaLive.com (press release), These data established the superior therapeutic activity of pralatrexate in models of human non-Hodgkin's lymphoma and provide further support for the Phase 1 ...
Rituxan Gets Added Clearance Feb 13, 2006
TheStreet.com ...type of immune-system cells. Rituxan is already approved to treat low-grade non-Hodgkin's lymphoma. The FDA approval, announced ...
FDA approves Rituxan for first-line lymphoma treatment Feb 13, 2006
Pharmaceutical Business Review ...approved Genentech and Biogen Idec's lymphoma drug Rituxan for use in the first-line treatment of patients with diffuse large B-cell non-Hodgkin's lymphoma, in ...
Anti-Lymphoma Drug Gets OK for New Use Feb 11, 2006
HealthCentral.com The Associated Press reports that the US Food and Drug Administration approved a new indication for Rituxan to treat certain types of non-Hodgkin's lymphoma. ...
Lessons from a consummate cancer survivor Feb 20, 2006
Stuff.co.nz, He was diagnosed with a low-grade, non-Hodgkin's lymphoma – a blood cancer. He asked the doctor the "eternal" question: "How long do I have?". ...
Combination therapy improves Acquired Immunodeficiency Syndrome ... Feb 27, 2006
News-Medical.net, Society, the study reveals that combination therapy showed the greatest benefit for HIV patients suffering from aggressive malignant non-Hodgkin's lymphoma. ...
New use for cancer drug OK'd Mar 1, 2006
Seattle Post Intelligencer Biogen Idec said. The drug, administered intravenously, was approved eight years ago to treat non-Hodgkin's lymphoma. Rituxan yielded ...
Accentia Biopharmaceuticals' Development Partner Requests Meeting ... Mar 1, 2006
Genetic Engineering News, Research. BiovaxID is a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkin's lymphoma. BiovaxID ...
Cancer drug Rituxan receives federal approval to treat rheumatoid ... Mar 1, 2006
San Jose Mercury News, The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's lymphoma. ...
The baby in the bathwater Mar 5, 2006
Ottawa Citizen, There is a disturbing rise in certain cancers in young adults: melanoma, testicular cancer, non-Hodgkin's lymphoma and thyroid cancer. ...
AROUND THE TOWNS Feb 23, 2006
Freeport Journal Standard, ...u “Lymphoma: Aggressive Non-Hodgkin's Lymphoma� with Dr. Henry Fung Rush University Medical Center. u “Lymphoma: Indolent ...
Human Genome Sciences: Human Genome Sciences Reports Financial ... Feb 13, 2006
Webbolt Business News (subscription), ...demonstrated that HGS-ETR1 was capable of producing clinical responses when administered as monotherapy in patients with advanced non-Hodgkin's lymphoma (NHL). ...
Koivu's Nightmare Gives Way to Dream Feb 26, 2006
Washington Post, Saku Koivu, center, whose case of non-Hodgkin's lymphoma was diagnosed in 2001, leads the Olympic men's hockey tournament in points. ...
Why Olympian must hit ground running to fight twin challenge Mar 2, 2006
Independent, An affable and approachable politician, Ming - as he is invariably known - overcame cancer after he was diagnosed with non-Hodgkin's lymphoma in 2002. ...
Key Events Nearing for Biogen Idec, but Upside Looks Limited Feb 15, 2006
TheStreet.com ...million. The company's other main product line is the oncology treatment Rituxan, which is indicated for non-Hodgkin's lymphoma. ...
Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
Reuters ...(BIIB.O: Quote, Profile, Research) on Tuesday said US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis ...
Biogen 4th-qtr profit nearly doubles Feb 15, 2006
MSN Money ...return to the US market, said on Wednesday its fourth-quarter profit nearly doubled on increased sales of its older MS drug and one for non-Hodgkin's lymphoma. ...
Rheumatoid Arthritis Drug Is Approved Feb 28, 2006
New York Times, ...later merged with Biogen. The drug was licensed to Genentech and was approved for non-Hodgkin's lymphoma in 1997. The drug is Genentech's ...
TECH TICKER Mar 1, 2006
San Jose Mercury News, ...candidates for Rituxan. Rituxan has been approved by the FDA since 1997 as a treatment for non-Hodgkin's lymphoma. Affymetrix stock ...
Stocks seen higher after steep fall Mar 1, 2006
Washington Post, ...will be in focus as both companies said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...
US stocks seen higher after steep fall Mar 1, 2006
Reuters.uk, ...(BIIB.O: Quote, Profile, Research) will be in focus as both companies said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment ...
Well-off women more likely to get skin cancer Feb 26, 2006
Irish Times, It also finds the incidence of, and deaths from, ovarian cancer and non-Hodgkin's lymphoma in the Republic are among the highest in western Europe. ...
Cancer Drug Approved for Rheumatoid Arthritis Mar 1, 2006
Forbes The FDA approval for RA patients comes more than eight years after the drug's initial approval for people with non-Hodgkin's lymphoma, according to USA Today. ...
Meet Ming and the Minx Mar 4, 2006
Scotland on Sunday, Elspeth also nursed him through their most difficult spell two years ago, when Campbell was diagnosed with Non-Hodgkin's Lymphoma. ...
RITUXAN: FIRST FDA-APPROVED TREATMENT TO IMPROVE SURVIVAL FOR ... Feb 22, 2006
PR Newswire (press release), Patients with non-Hodgkin’s lymphoma, cancer of the lymphoid tissue in which lymphocytes proliferate and grow uncontrollably, now have a new weapon in the ...
Ming the Merciless hopes to charm electorate Mar 3, 2006
Yorkshire Post Today, 1987, and held a range of frontbench jobs before taking time out from Parliament to undergo chemotherapy after being diagnosed with non-Hodgkin's lymphoma in ...
Business Briefs Feb 28, 2006
Newark Star Ledger, And finally ... Genentech and Biogen Idec said US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...
Roche Drug Approved for Rheumatoid Arthritis Mar 1, 2006
Smartmoney.com Rituxan - already the company's sales growth driver and its best selling drug, as a treatment for non-Hodgkin's lymphoma - could add CHF900 million to CHF2 ...
Feds OK Cancer Drug For Rheumatoid Arthritis Mar 1, 2006
KETV.com, Rituxan is already the nation's best-selling cancer drug, having won approval to treat non-Hodgkin's lymphoma more than eight years ago. ...
Rituxan OK'd for Rheumatoid Arthritis Mar 1, 2006
WebMD ...used to treat cancer. It's been used since 1997 to treat non-Hodgkin's lymphoma, a cancer of the lymph nodes. "The FDA approval ...
FDA Approves Rituxan for Refractory Rheumatoid Arthritis Mar 1, 2006
MedPage Today, ROCKVILLE, Md., March 1 - The FDA today approved Rituxan (rituximab), a therapy for non-Hodgkin's lymphoma, for treatment of rheumatoid arthritis. ...
FDA Approves Cancer Drug Rituxan Feb 10, 2006
All Headline News New York, New York (AHN) - The US Food and Drug Administration has approved the drug Rituxan, which is used to treat certain types of non-Hodgkin's lymphoma. ...
Cancer Drug Approved for Arthritis Sufferers Mar 2, 2006
WLNS, ...arthritis. The FDA action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's Lymphoma. ...
Cougar Biotechnology to Present at Cowen & Co. 26th Annual Health ... Mar 3, 2006
Genetic Engineering News, ...which is currently being tested in a Phase I clinical trial in prostate cancer, CB3304, which is currently in a Phase I trial in non-Hodgkin's lymphoma and ...
Cancer Drug May Double As an Arthritis Treatment Mar 2, 2006
International News Service, The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non- Hodgkin's lymphoma. ...
Genentech's Rituxan given arthritis OK Mar 2, 2006
Pharmaceutical Business Review ...treatment of rheumatoid arthritis. The approval expands on the drug's indication in non-Hodgkin's lymphoma. Rituxan has been specifically ...
Genentech/Biogen Idec: Rituxan further expands its options Mar 2, 2006
Pharmaceutical Business Review Rituxan (rituximab) has been available for non-Hodgkin's lymphoma since 1997 and recently received an expanded approval in this area. ...
Genentech, Biogen cancer drug approved for new indication Mar 2, 2006
New Ratings Remicade and Humira. Rituxan was first approved eight years ago for the treatment of non-Hodgkin's lymphoma. Rheumatoid arthritis ...
UPDATE 2-Accentia says cancer vaccine boosts survival 25 Jan 2006
Reuters Among 23 non-Hodgkin's lymphoma patients, 89 percent survived 3.8 years after getting the cancer vaccine following a standard chemotherapy, the company said. ...
I'VE HAD TERRIBLE INSULTS ABOUT MY HAIR ..WHAT IF I REALLY DID ... 25 Jan 2006
Mirror.co.uk, ..."When they told me Alice was going to get Non-Hodgkin's Lymphoma - a type of leukaemia - I wanted to do my best to be true to people's experiences," she says. ...
Genentech Share Price Currently A 'Good Entry Point' 25 Jan 2006
Forbes ...as “a number of potential new indications� for Genentech’s colorectal cancer drug, Avastin, as well as for Rituxan, a treatment for non-Hodgkin's lymphoma ...
Trubion Names Michelle Burris Senior Vice President and CFO 25 Jan 2006
Yahoo! News (press release) ...officer, where she participated in the development and approval of Bexxar®, an antibody drug approved for the treatment of non-Hodgkin's lymphoma, the ...
Subcutaneous Genasense(R) Trial Initiated in Patients with Solid ... 25 Jan 2006
PR Newswire (press release), However, a prolonged subcutaneous infusion method using the existing IV formulation was studied in patients with advanced non-Hodgkin's lymphoma, which showed ...
MedPanel Launches Profiles in Non-Hodgkin's Lymphoma -- United ... Jan 12, 2006
Yahoo! News (press release) 12 /PRNewswire/ -- MedPanel, a leader in online medical market intelligence, announces the launch of Profiles in Non-Hodgkin's Lymphoma -- United States & ...
Non-Hodgkin's lymphoma risk increased with prolonged high HIV ... Jan 10, 2006
Aidsmap, Prolonged high HIV viral loads are associated with an increased risk of non-Hodgkin's lymphoma (NHL) independent of CD4 cell counts, according to data from the ...
Fixture on the court: Bud Epplett's spirit, generosity at YMCA was ... Jan 23, 2006
The Register-Guard, YMCA, where most players range from teenagers to men in their 50s - a court where Bud played until about two months before his death of non-Hodgkin's lymphoma. ...
Be your own health-care advocate Jan 24, 2006
Indianapolis Star, Modern Medicine and How You Can, Too" (DaCapo Press, $25), Stephen H. Schneider uses his own successful battle against a rare form of non-Hodgkin's lymphoma as ...
MDS Pharma Services Named Preferred Contract Research Organization ... Jan 23, 2006
PharmaLive.com (press release), An incurable but treatable disease, multiple myeloma is a cancer of the plasma cell and the second most prevalent blood cancer after non-Hodgkin's lymphoma. ...
In Sudan, faith guides their work Jan 21, 2006
Milwaukee Journal Sentinel (subscription), ...who served in a part of Vietnam where the toxic defoliant Agent Orange was used, Dennis Klepp, 54, has been battling cancer - non-Hodgkin's lymphoma - for ...
Human Genome Sciences Reports on Progress Toward Commercialization ... Jan 10, 2006
PR Newswire (press release), HGS-ETR1 is also moving forward. Our Phase 2 trial of HGS-ETR1 as monotherapy produced clinical responses in patients with non-Hodgkin's lymphoma. ...
Cytokinetics Raising $33M For Clinic, Corporate Uses Jan 18, 2006
BioWorld Online (subscription), In September, Cytokinetics restructured the deal to take the lead in evaluating SB-743921 in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma ...
FDA Adds new Cancer Warning to Eczema Cream and Ointment Labels ... Jan 19, 2006
Best Syndication, ...to L&S, users should watch for T-Cell Lymphom, Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), Hodgkin's Lymphoma (HL), Non-Hodgkin's Lymphoma. ...
BiovaxID, Personalized Anti-Cancer Vaccine from Biovest ... Jan 10, 2006
PharmaLive.com (press release), In this single-arm, Phase 2 study, patients with follicular B-cell Non-Hodgkin's Lymphoma (NHL) in continuous first clinical remission six months following ...
A War's Unwelcome Vestiges Jan 17, 2006
TheDay (subscription), Orange. In February 2005, Sorensen was diagnosed with non-Hodgkin's lymphoma. Last September, the VA approved compensation for him. ...
ZEVALIN® Radioimmunotherapy May Play Greater Role In Combination ... Dec 27, 2005
Medical News Today (press release), ...in refractory and hard-to-treat cancers, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular non-Hodgkin's lymphoma (FL ...
CancerVax, Micromet Enter $127M Merger Agreement Jan 9, 2006
BioWorld Online (subscription), ...cancer products in clinical development: MT201 in Phase II trials for metastatic breast and prostate cancers, and MT103 in Phase I for non-Hodgkin's lymphoma. ...
Favrille drug gets fast track designation Jan 12, 2006
Reuters NEW YORK, Jan 12 (Reuters) - Favrille Inc. (FVRL.O: Quote, Profile, Research) on Thursday said its treatment for a type of non-Hodgkin's lymphoma had received ...
Accentia says cancer vaccine encouraging in trial Jan 10, 2006
Reuters ...(ABPI.O: Quote, Profile, Research) said on Tuesday that its experimental cancer vaccine appeared to help patients whose non-Hodgkin's lymphoma was in remission ...
UPDATE 1-Favrille drug gets fast track, shares jump 33 pct Jan 12, 2006
Reuters ...(FVRL.O: Quote, Profile, Research) on Thursday said its vaccine treatment for a type of non-Hodgkin's lymphoma had received fast-track designation from the US ...
Dendreon lays off 34 as CFO departs Jan 21, 2006
Seattle Post Intelligencer ...financial officer, she is known in the Seattle biotechnology industry for helping to win federal approval of Bexxar, a treatment for non-Hodgkin's lymphoma. ...
Favrille lymphoma drug fast tracked Jan 12, 2006
United Press International SAN DIEGO, Jan. 12 (UPI) -- Favrille said Thursday it has received fast-track status for its non-Hodgkin's lymphoma drug FavId. ...
Favrille Receives FDA Fast Track Designation for FavId, Lead ... Jan 12, 2006
Yahoo! News (press release) FDA) has granted Fast Track designation for FavId®, the Company's lead product candidate for the treatment of B-cell follicular non-Hodgkin's lymphoma (NHL). ...
NHL Vaccine Encouraging in Trial Jan 11, 2006
Cancerpage.com,
| |
